23.04 USD
▲+0.56+2.49%
盘后 22.66 -1.64%
2026-09-04
市值
$1.46B
市盈率
—
EPS
-19.74
股息率
—
52 周区间
17.22 – 25.93
成交量
227.44K
Beta
—
目标价
52.25
52W 低 17.2252W 高 25.93
价格走势
公司简介
Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. The company's pipeline includes LTG-001, an oral NaV1.8 inhibitor designed to provide fast-acting, opioid-sparing relief for the treatment of acute pain; LTG-321, a NaV1.8 inhibitor candidate developed for the treatment of chronic musculoskeletal pain, starting with osteoarthritis; and LTG-418, a NaV1.8 inhibitor developed for the treatment of acute and chronic pain. Latigo Biotherapeutics, Inc. was formerly k...